Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma

BACKGROUND: The oncogenic role of excision repair cross-complementation group 6-like (ERCC6L) has been revealed in several cancers recently, but little is known about its expression and function in hepatocellular carcinoma (HCC). METHODS: Utilizing public data from Human Protein Atlas (HPA) and The...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastrointest Oncol
Hlavní autoři: Yu, Bin, Liang, Han, Ye, Qifa, Wang, Yanfeng
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657825/
https://ncbi.nlm.nih.gov/pubmed/33209494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-192
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky